Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Header Top Menu

  • News & Featured Stories
  • Media
  • Careers
  • Contact Us
  • Our Science

    Sub Menu 1

    • Pfizer in the UK
      • Our History
      • Pharmaceutical Sciences
      • Devices Centre of Excellence
      • Global Regulatory Affairs
      • Material Characterisation Team
      • Anti-Counterfeit Laboratory
    • Our Therapy Areas
      • Anti-Infectives
      • Inflammation and Immunology
      • Internal Medicine
      • Oncology
      • Rare Disease
      • Vaccines

    Sub Menu 2

    • Developing New Medicines
      • Clinical Trials
      • Pipeline
    • Research partnerships
      • ADDoPT
      • Innovative Target Exploration Network (ITEN)
      • INSPIRE Programme
      • Medical Research Council Collaboration
      • The Stratified Medicine Programme
      • Partnership with Regeneron for UK Biobank exome sequencing
    • Breakthroughs that change patients’ lives
    Hot Topic

    What is a Variant?

    What is a Variant
  • Products

    Sub Menu 4

    • Prescription medicines

    Sub Menu 5

    • Safety of Medicines
      • Medicines Regulation
      • Reporting Side Effects
      • Counterfeit Medicines
    Hot Topic

    How Does a Protease Inhibitor Work?

    Protease Inhibitor
  • Responsibility

    Sub Menu 7

    • Transparency
      • HCP & HCO Annual Disclosure Reports
      • Healthcare Organisation Grants
      • Research and Development Funding
      • Patient Organisation Funding and Support
    • Codes of Conduct
      • Gender Pay Gap Report
      • Environmental, Health and Safety Policy
      • Section 172 Statements
      • Pfizer UK Modern Slavery Statement
      • Pfizer UK Tax Strategy

    Sub Menu 8

    • Environmental Sustainability
      • Climate Action
      • Global Actions
      • Our Partnerships & Commitments
      • Sustainable Medicines
      • UK Actions
    • Insurance Details
    • Animal Welfare
    Hot Topic

    How Pfizer is Fighting Climate Change

    How Pfizer is Fighting Climate Change
  • UK Society

    Sub Menu 10

    • Social Investment
      • Volunteering and Fundraising
      • Medicines Donations
    • Raising Public Awareness
      • Change the Course
      • Pfizer Sponsors Science Museum Group's 'Cancer Revolution' Exhibition
      • Pfizer Sponsors the Superhero Series
      • Pfizer sponsors Science Museum exhibition 'Superbugs'
      • Pfizer at the British Science Festival
      • Turning Heads at Westminster

    Sub Menu 11

    • Science Education
      • Developing Science Talent
      • 'Superbugs Join The Fight' School Programme
      • Online Learning
        • Student Education Area
        • Teacher Resources
      • Community Lab
      • Career Talks
      • Lab in a Box
    • Pfizer Worldwide
      • Global Health Fellows
      • Global Aid and Emergency Relief
      • International Trachoma Initiative
    Hot Topic

    VacciNation: tackling health inequalities across England

    VacciNation report
  • UK Health System

    Sub Menu 16

    • Working with the NHS and other Healthcare Organisations
      • Collaborative Working
        • Collaborative Working Project between Lloyds Pharmacy and Pfizer Vaccines
        • Joint Working
      • Donations and Grants
        • Independent Medical Grants and Donations
        • Donations of Goods, Services and Benefit in Kind
        • Grants
        • Donations and Grants Enquiry Form
    • Working with Healthcare Professionals
      • FAQs: Working with Healthcare Professionals
      • Pharmacy
      • Healthcare Professionals Congress Sponsorship

    Sub Menu 17

    • Working with Patient Organisations
      • Patient Involvement in Research and Development
      • Our ongoing partnership with the UK Sepsis Trust
      • Partnering with the NIHR and young people on clinical research
    • Pfizer Healthcare Hub
      • Pfizer Healthcare Hub: 2018
      • Pfizer Healthcare Hub: 2017
      • Connect with the Hub
    Hot topic

    Putting patients at the heart of clinical trials

    Patients at heart of clinical trials
  • News & Featured Stories
  • Media
  • Careers

    Carrers

    • Search Current Vacancies
    • Apprenticeships
      • Apprenticeship Vacancies
    • Undergraduate Placements
      • Undergraduate Vacancies
    • Meet our people
    • UK Top Employer
    • How Pfizer is fostering meaningful growth for every colleague, everywhere
  • Contact Us
  • Footer links

    Footer mobile menu

    • Footer Menu
    • Footer menu
      • Contact Us
      • Cookie Policy
      • Terms of Use
      • Privacy Policy
      • Sitemap
    • Footer social item
      • Facebook
      • Twitter
      • Instagram
      • YouTube

VacciNation: a vision for UK immunisation

VacciNation: a vision for UK immunisation
News & Featured Stories/ VacciNation: a vision for UK immunisation
24/09/2020

Pfizer Vaccines
Pfizer UK

Could a new approach to prevention create a healthier and more resilient Britain? Today, Pfizer has launched ‘VacciNation’ - a vision for protecting the health, wealth and resilience of the UK by unlocking the personal and societal value of vaccines at every stage of life.

 

VacciNation sets out a series of thought-provoking ideas to address systemic challenges in the use of, and access to, life-changing and life-saving vaccines, while cementing the UK’s position at the forefront of research and innovation.

These ideas are focused on achieving three priorities:

  • Maximising the value that vaccination can deliver to the nation’s health and the UK economy
  • Unleashing the potential of vaccination across society to tackle major health challenges, regardless of age
  • Making vaccination a priority across the NHS

The UK has a long-standing and proud heritage in vaccine development. VacciNation highlights the potential to build on this legacy and secure the UK’s position as a global leader in preventative healthcare well into the future.

Many major health economies prioritise investment in medicines and cures to treat ill health over keeping people well. Today in the UK, we spend £97 billion a year on treating diseases and only £8 billion on preventing them.1 VacciNation calls for a rebalance, allowing us to better understand the longer-term and lifelong benefits of vaccination in maintaining population health and reducing health inequalities, as well as realising significant economic value.2

VacciNation also highlights the potential for the NHS to make vaccination a priority. One of the opportunities is to put adult vaccinations on a par with childhood vaccinations, helping us better meet the demands of a growing and ageing population, and protecting some of the most vulnerable from disease.
 

VacciNation sets out how a population better protected from disease is within our reach. Vaccination has saved more lives and prevented more serious diseases than any advance in recent medical history.3,4 In fact, only clean water rivals vaccines at reducing infectious diseases and deaths.5 Unlocking the full potential of vaccination at all stages of life  is an opportunity too important to miss. In the last year in England, just 1 in 8 65 year olds were immunised against pneumonia.6 And while those between 70-79 are eligible for vaccination against shingles, by the age of 76, around 1 in 4 are still unvaccinated.7 There is a need to take urgent action to equip individuals with the right information, as well as provide easy, convenient access to improve uptake of all recommended vaccinations across society." 

Dr Gillian Ellsbury, Vaccines Medical Director, Pfizer UK & Ireland

With the release of VacciNation today, Pfizer is looking to build strong, collaborative partnerships to support the UK in tackling the challenges faced by the NHS and to deliver a new generation of innovative vaccines to support health throughout life.

Download the full report

VacciNation: a vision for UK immunisation

Published September 2020

 

References

  1. DHSC. Prevention is better than cure: Our vision to help you live well for longer. Accessed Nov 2021
  2. Quilici S, Smith R, et al. Role of vaccination in economic growth. Accessed Nov 2021
  3. ABPI. Vaccines. Accessed Nov 2021
  4. WHO. Vaccine safety and false contraindications to vaccination. Accessed Nov 2021
  5. WHO. Vaccination greatly reduces disease, disability, death and inequity worldwide. Accessed Nov 2021
  6. Public Health England. Pneumococcal Polysaccharide Vaccine (PPV) coverage report, England, April 2019 to March 2020. Accessed Nov 2021
  7. Public Health England. Shingles (quarter 3) vaccine coverage report (adults eligible from April to December 2019 and vaccinated to end-March 2020) in England. Accessed Nov 2021

 

PP-PFE-GBR-4224 / November 2021

Related Hot Topics
Patient View 2021
Pfizer UK ranked first for overall corporate reputation by PatientView Survey…
AMR Reimbursement Pilot Launch
World First Cross-Industry Initiative Launches in the Continued Fight Against…
COVID-19 Vaccine Equity
Working To Reach Everyone, Everywhere
VacciNation report
VacciNation: tackling health inequalities across England
Patients at heart of clinical trials
Why putting patients at the heart of Pfizer UK’s clinical trials continues to…
Infection Management Coalition Paper
Cross-Industry Coalition Tackling ‘Hidden Pandemic’ of Antibiotic Resistant…
Maternal Immunisation
Protecting Babies from Inside the Womb
Blueprint for gene therapy adoption
Pfizer UK launch blueprint for the UK adoption of cell and gene therapies
Tags
UK Health System
Vaccines

Footer

  • Contact Us
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Sitemap

Footer aside

  • Footer Aside
    • Facebook
    • Twitter
    • Instagram
    • YouTube

Copyright © 2017-2022 Pfizer Limited. PP-PFE-GBR-4248 / Nov 2021. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427